Neglected Tropical Diseases in Burkina Faso
In all countries supported by USAID’s NTD Program, country ownership of the Program is a core principle and is critical to successful implementation and long-term sustainability.
USAID support for NTD control in Burkina Faso is provided through a cooperative agreement with RTI, with a sub-grant to Schistosomiasis Control Initiative (SCI). SCI works alongside the Burkina Faso government and the Ministry of Health, and also engages with a wide range of dedicated local stakeholders, including the World Health Organization – Burkina Faso, Réseau International Schistosomoses Environnement Amenagements et Lutte and the Liverpool NTD Support Center.
USAID’s support for integrated NTD control in Burkina Faso began with the launch of a national stakeholders meeting in January 2007. Results of activities carried out with United States Congressional funding in Burkina Faso to date* include:
- Mass Drug Administration
- First round of treatment was carried out in:
- August 2007 in three districts
- December 2007-July 2008 in 29 districts
- Second round of treatment was carried out in:
- December 2007-July 2008 in 32 districts
- Third round planned for January-July 2009 in 32 districts
- Treatment
- A total of 10.41 million treatments have been provided since 2007
- 1.01 million people were treated in August 2007
- 4.42 million people were treated from December 2007-July 2008
- Mapping
- 33 districts were mapped for trachoma (blinding eye infection) prevalence in 2007
- 16 districts were mapped for trachoma (blinding eye infection) prevalence in 2008
- Training
- 3,156 people were trained to deliver integrated treatment in 2007
- 50,283 people were trained to deliver integrated treatment in 2008
Upcoming Program Activities
>
The Program will continue to sponsor the above mentioned key activities. In the upcoming year, it is expected that through the Program:
- 8.5 million Burkinabe will receive needed treatments in 32 districts of the country
Success Stories
*Updated February 2009